nach oben

Inflammation

Erschienen in:

26.02.2020 | Original Article

N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis

verfasst von: Guangqi Yan, Yan Guo, Jingwen Guo, Qiang Wang, Chunyu Wang, Xue Wang

Erschienen in: Inflammation | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Chronic inflammatory diseases affect bone and teeth health tremendously. Characterized by osteolytic lesion and hyperactive osteoclastogenesis, inflammatory bone diseases are short of effective therapeutics and therefore highlight the importance of understanding pathogenesis and developing ideal medications. Reactive oxygen species (ROS) play a prominent role in the innate immune response of activated macrophages, as well as in the physiological signaling of osteoclasts (OCs) differentiation. N-acetylcysteine (NAC) is a potent ROS scavenger and a potential option for treating diseases characterized by excessive ROS generation. However, whether NAC can protect physiological bone remodeling from in vivo inflammatory conditions is largely undefined. We applied NAC treatment on lipopolysaccharide (LPS)-induced inflammatory osteolysis mice model and found that NAC could attenuate bone erosion and protect mice against LPS-induced osteolysis, due to the suppressive effect on osteoclastogenesis and stimulated effect on osteogenesis. Moreover, in vitro study demonstrated that, in OC precursors (pre-OCs), LPS-stimulated expressions of OC marker genes, such as tartrate-resistant acid phosphatase type 5 (Acp5), cathepsin K (Ctsk), OC stimulatory transmembrane protein (Oc-stamp), dendritic cell–specific transmembrane protein (Dc-stamp), and nuclear factor of activated T cells 1 (NFATc1), were all reduced because of the NAC pretreatment, thereby adversely affecting OC function including F-actin ring formation and bone resorption. Further mechanism study showed that NAC blocked LPS-induced ROS formation in both macrophages and pre-OCs, cutting off the LPS-stimulated autocrine/paracrine mechanism during inflammatory osteolysis. Our findings reveal that NAC attenuates inflammatory osteolysis via the elimination of ROS formation during LPS-stimulated osteoclastogenesis, and provide a potential therapeutic approach to treat inflammatory bone disease.

Kanno, Y., A. Ishisaki, E. Kawashita, H. Kuretake, K. Ikeda, and O. Matsuo. 2016. uPA attenuated LPS-induced inflammatory osteoclastogenesis through the plasmin/PAR-1/Ca(2+)/CaMKK/AMPK Axis. International Journal of Biological Sciences 12 (1): 63–71. https://doi.org/10.7150/ijbs.12690.CrossRefPubMedPubMedCentral

Xiao, Y., C. Li, M. Gu, H. Wang, W. Chen, G. Luo, G. Yang, Z. Zhang, Y. Zhang, G. Xian, Z. Li, and P. Sheng. 2018. Protein disulfide Isomerase silence inhibits inflammatory functions of macrophages by suppressing reactive oxygen species and NF-kappaB pathway. Inflammation 41 (2): 614–625. https://doi.org/10.1007/s10753-017-0717-z.CrossRefPubMed

Gruber, R. 2019. Osteoimmunology: inflammatory osteolysis and regeneration of the alveolar bone. Journal of Clinical Periodontology 46 (Suppl 21): 52–69. https://doi.org/10.1111/jcpe.13056.CrossRefPubMed

Boyce, B.F., E.M. Schwarz, and L. Xing. 2006. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Current Opinion in Rheumatology 18 (4): 427–432. https://doi.org/10.1097/01.bor.0000231913.32364.32.CrossRefPubMed

Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423 (6937): 337–342. https://doi.org/10.1038/nature01658.CrossRefPubMed

Charles, J.F., and A.O. Aliprantis. 2014. Osteoclasts: more than ‘bone eaters’. Trends in Molecular Medicine 20 (8): 449–459. https://doi.org/10.1016/j.molmed.2014.06.001.CrossRefPubMedPubMedCentral

Bandow, K., A. Maeda, K. Kakimoto, J. Kusuyama, M. Shamoto, T. Ohnishi, and T. Matsuguchi. 2010. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochemical and Biophysical Research Communications 402 (4): 755–761. https://doi.org/10.1016/j.bbrc.2010.10.103.CrossRefPubMed

Guo, C., L. Yuan, J.G. Wang, F. Wang, X.K. Yang, F.H. Zhang, J.L. Song, X.Y. Ma, Q. Cheng, and G.H. Song. 2014. Lipopolysaccharide (LPS) induces the apoptosis and inhibits osteoblast differentiation through JNK pathway in MC3T3-E1 cells. Inflammation 37 (2): 621–631. https://doi.org/10.1007/s10753-013-9778-9.CrossRefPubMed

Zou, W., and Z. Bar-Shavit. 2002. Dual modulation of osteoclast differentiation by lipopolysaccharide. Journal of Bone and Mineral Research 17 (7): 1211–1218. https://doi.org/10.1359/jbmr.2002.17.7.1211.CrossRefPubMed

10.

Nason, R., J.Y. Jung, and R.A. Chole. 2009. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. Journal of the Association for Research in Otolaryngology 10 (2): 151–160. https://doi.org/10.1007/s10162-008-0153-8.CrossRefPubMedPubMedCentral

11.

Bedard, K., and K.H. Krause. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. 87 (1): 245–313. https://doi.org/10.1152/physrev.00044.2005.

12.

Jezek, J., K.F. Cooper, and R. Strich. 2018. Reactive oxygen species and mitochondrial dynamics: The yin and yang of mitochondrial dysfunction and cancer progression. Antioxidants (Basel) 7 (1). https://doi.org/10.3390/antiox7010013.

13.

Callaway, D.A., and J.X. Jiang. 2015. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases. Journal of Bone and Mineral Metabolism 33 (4): 359–370. https://doi.org/10.1007/s00774-015-0656-4.CrossRefPubMed

14.

Lee, N.K., Y.G. Choi, J.Y. Baik, S.Y. Han, D.W. Jeong, Y.S. Bae, N. Kim, and S.Y. Lee. 2005. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106 (3): 852–859. https://doi.org/10.1182/blood-2004-09-3662.CrossRefPubMed

15.

Schroder, K. 2019. NADPH oxidases in bone homeostasis and osteoporosis. Free Radical Biology & Medicine 132: 67–72. https://doi.org/10.1016/j.freeradbiomed.2018.08.036.CrossRef

16.

Srinivasan, S., A. Koenigstein, J. Joseph, L. Sun, B. Kalyanaraman, M. Zaidi, and N.G. Avadhani. 2010. Role of mitochondrial reactive oxygen species in osteoclast differentiation. Annals of the New York Academy of Sciences 1192: 245–252. https://doi.org/10.1111/j.1749-6632.2009.05377.x.CrossRefPubMedPubMedCentral

17.

Bai, X.C., D. Lu, A.L. Liu, Z.M. Zhang, X.M. Li, Z.P. Zou, W.S. Zeng, B.L. Cheng, and S.Q. Luo. 2005. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. The Journal of Biological Chemistry 280 (17): 17497–17506. https://doi.org/10.1074/jbc.M409332200.CrossRefPubMed

18.

Deng, S., G. Dai, S. Chen, Z. Nie, J. Zhou, H. Fang, and H. Peng. 2019. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3beta signaling pathway. Biomedicine & Pharmacotherapy 110: 602–608. https://doi.org/10.1016/j.biopha.2018.11.103.CrossRef

19.

Dai, P., Y. Mao, X. Sun, X. Li, I. Muhammad, W. Gu, D. Zhang, Y. Zhou, Z. Ni, J. Ma, and S. Huang. 2017. Attenuation of oxidative stress-induced osteoblast apoptosis by curcumin is associated with preservation of mitochondrial functions and increased Akt-GSK3beta signaling. Cellular Physiology and Biochemistry 41 (2): 661–677. https://doi.org/10.1159/000457945.CrossRefPubMed

20.

Almeida, M., L. Han, E. Ambrogini, R.S. Weinstein, and S.C. Manolagas. 2011. Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts. The Journal of Biological Chemistry 286 (52): 44326–44335. https://doi.org/10.1074/jbc.M111.283481.CrossRefPubMedPubMedCentral

21.

Yamada, M., N. Tsukimura, T. Ikeda, Y. Sugita, W. Att, N. Kojima, K. Kubo, T. Ueno, K. Sakurai, and T. Ogawa. 2013. N-acetyl cysteine as an osteogenesis-enhancing molecule for bone regeneration. Biomaterials 34 (26): 6147–6156. https://doi.org/10.1016/j.biomaterials.2013.04.064.CrossRefPubMed

22.

Mokhtari, V., P. Afsharian, M. Shahhoseini, S.M. Kalantar, and A. Moini. 2017. A review on various uses of N-acetyl cysteine. Cell Journal 19 (1): 11–17.PubMed

23.

Lee, Y.H., G. Bhattarai, I.S. Park, G.R. Kim, G.E. Kim, M.H. Lee, and H.K. Yi. 2013. Bone regeneration around N-acetyl cysteine-loaded nanotube titanium dental implant in rat mandible. Biomaterials 34 (38): 10199–10208. https://doi.org/10.1016/j.biomaterials.2013.08.080.CrossRefPubMed

24.

Jiao, Y., S. Ma, Y. Wang, J. Li, L. Shan, Q. Liu, Y. Liu, Q. Song, F. Yu, H. Yu, H. Liu, L. Huang, and J. Chen. 2016. N-acetyl cysteine depletes reactive oxygen species and prevents dental monomer-induced intrinsic mitochondrial apoptosis in vitro in human dental pulp cells. PLoS One 11 (1): e0147858. https://doi.org/10.1371/journal.pone.0147858.CrossRefPubMedPubMedCentral

25.

Lean, J.M., J.T. Davies, K. Fuller, C.J. Jagger, B. Kirstein, G.A. Partington, Z.L. Urry, and T.J. Chambers. 2003. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. The Journal of Clinical Investigation 112 (6): 915–923. https://doi.org/10.1172/JCI18859.CrossRefPubMedPubMedCentral

26.

Jun, J.H., S.H. Lee, H.B. Kwak, Z.H. Lee, S.B. Seo, K.M. Woo, H.M. Ryoo, G.S. Kim, and J.H. Baek. 2008. N-acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells. Journal of Cellular Biochemistry 103 (4): 1246–1255. https://doi.org/10.1002/jcb.21508.CrossRefPubMed

27.

Xu, D.X., Y.H. Chen, H. Wang, L. Zhao, J.P. Wang, and W. Wei. 2005. Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicological Sciences 88 (2): 525–533. https://doi.org/10.1093/toxsci/kfi300.CrossRefPubMed

28.

Sadowska, A.M., Y. Keenoy, B. Manuel, and W.A. De Backer. 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulmonary Pharmacology & Therapeutics 20 (1): 9–22. https://doi.org/10.1016/j.pupt.2005.12.007.CrossRef

29.

Roseguini, B.T., L.M. Silva, T.G. Polotow, M.P. Barros, C. Souccar, and S.W. Han. 2015. Effects of N-acetylcysteine on skeletal muscle structure and function in a mouse model of peripheral arterial insufficiency. Journal of Vascular Surgery 61 (3): 777–786. https://doi.org/10.1016/j.jvs.2013.10.098.CrossRefPubMed

30.

Wu, H., B. Hu, X. Zhou, C. Zhou, J. Meng, Y. Yang, X. Zhao, Z. Shi, and S. Yan. 2018. Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway. Cell Death & Disease 9 (5): 498. https://doi.org/10.1038/s41419-018-0540-y.CrossRef

31.

Meng, J., C. Zhou, W. Zhang, W. Wang, B. He, B. Hu, G. Jiang, Y. Wang, J. Hong, S. Li, J. He, S. Yan, and W. Yan. 2019. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-kappaB and Akt signalling. Journal of Cellular and Molecular Medicine 23 (10): 6730–6743. https://doi.org/10.1111/jcmm.14551.CrossRefPubMedPubMedCentral

32.

Zhai, Z.J., H.W. Li, G.W. Liu, X.H. Qu, B. Tian, W. Yan, Z. Lin, T.T. Tang, A. Qin, and K.R. Dai. 2014. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. British Journal of Pharmacology 171 (3): 663–675. https://doi.org/10.1111/bph.12463.CrossRefPubMedPubMedCentral

33.

Bouxsein, M.L., S.K. Boyd, B.A. Christiansen, R.E. Guldberg, K.J. Jepsen, and R. Muller. 2010. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. Journal of Bone and Mineral Research 25 (7): 1468–1486. https://doi.org/10.1002/jbmr.141.CrossRefPubMed

34.

Yan, G., X. Wang, M. Yang, L. Lu, and Q. Zhou. 2017. Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219. American Journal of Cancer Research 7 (9): 1899–1912.PubMedPubMedCentral

35.

Li, Z., C. Li, Y. Zhou, W. Chen, G. Luo, Z. Zhang, H. Wang, Y. Zhang, D. Xu, and P. Sheng. 2016. Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells. American Journal of Physiology. Endocrinology and Metabolism 310 (5): E355–E366. https://doi.org/10.1152/ajpendo.00309.2015.CrossRefPubMed

36.

Battaglino, R., D. Kim, J. Fu, B. Vaage, X.Y. Fu, and P. Stashenko. 2002. c-myc is required for osteoclast differentiation. Journal of Bone and Mineral Research 17 (5): 763–773. https://doi.org/10.1359/jbmr.2002.17.5.763.CrossRefPubMed

37.

Yan, G.Q., X. Wang, F. Yang, M.L. Yang, G.R. Zhang, G.K. Wang, and Q. Zhou. 2017. MicroRNA-22 promoted osteogenic differentiation of human periodontal ligament stem cells by targeting HDAC6. Journal of Cellular Biochemistry 118 (7): 1653–1658. https://doi.org/10.1002/jcb.25931.CrossRefPubMed

38.

Pei, Y., H. Liu, Y. Yang, Y. Yang, Y. Jiao, F.R. Tay, and J. Chen. 2018. Biological activities and potential oral applications of N-acetylcysteine: progress and prospects. Oxidative Medicine and Cellular Longevity 2018: 2835787. https://doi.org/10.1155/2018/2835787.CrossRefPubMedPubMedCentral

39.

Sanders, K.M., M.A. Kotowicz, and G.C. Nicholson. 2007. Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study. Translational Research 150 (4): 215. https://doi.org/10.1016/j.trsl.2007.03.012.CrossRefPubMed

40.

Kong, L., R. Ma, X. Yang, Z. Zhu, H. Guo, B. He, B. Wang, and D. Hao. 2017. Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines. International Immunopharmacology 51: 31–39. https://doi.org/10.1016/j.intimp.2017.07.003.CrossRefPubMed

41.

Wu, Z., H. Wu, C. Li, F. Fu, J. Ding, S. Shao, K. Li, X. Yu, Y. Su, J. Liang, X. Lin, G. Yuan, J. Zhou, F. Song, J. Zhao, J. Xu, Q. Liu, and F. Xu. 2019. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways. Journal of Cellular Physiology 234 (10): 17812–17823. https://doi.org/10.1002/jcp.28408.CrossRefPubMed

42.

Ponzetti, M., and N. Rucci. 2019. Updates on osteoimmunology: what’s new on the cross-talk between bone and immune system. Front Endocrinol (Lausanne) 10: 236. https://doi.org/10.3389/fendo.2019.00236.CrossRef

43.

Aruoma, O.I., B. Halliwell, B.M. Hoey, and J. Butler. 1989. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biology & Medicine 6 (6): 593–597. https://doi.org/10.1016/0891-5849(89)90066-x.CrossRef

44.

Cotgreave, I.A. 1997. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Advances in Pharmacology 38: 205–227.CrossRef

45.

Ohnishi, T., K. Bandow, K. Kakimoto, J. Kusuyama, and T. Matsuguchi. 2014. Long-time treatment by low-dose N-acetyl-L-cysteine enhances proinflammatory cytokine expressions in LPS-stimulated macrophages. PLoS One 9 (2): e87229. https://doi.org/10.1371/journal.pone.0087229.CrossRefPubMedPubMedCentral

46.

Sprong, R.C., A.M. Winkelhuyzen-Janssen, C.J. Aarsman, J.F. van Oirschot, T. van der Bruggen, and B.S. van Asbeck. 1998. Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. American Journal of Respiratory and Critical Care Medicine 157 (4 Pt 1): 1283–1293. https://doi.org/10.1164/ajrccm.157.4.9508063.CrossRefPubMed

47.

Oikawa, S., K. Yamada, N. Yamashita, S. Tada-Oikawa, and S. Kawanishi. 1999. N-acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesis 20 (8): 1485–1490. https://doi.org/10.1093/carcin/20.8.1485.CrossRefPubMed

48.

Paintlia, M.K., A.S. Paintlia, A.K. Singh, and I. Singh. 2008. Attenuation of lipopolysaccharide-induced inflammatory response and phospholipids metabolism at the feto-maternal interface by N-acetyl cysteine. Pediatric Research 64 (4): 334–339. https://doi.org/10.1203/PDR.0b013e318181e07c.CrossRefPubMedPubMedCentral

Titel: N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis
verfasst von: Guangqi Yan
Yan Guo
Jingwen Guo
Qiang Wang
Chunyu Wang
Xue Wang
Publikationsdatum: 26.02.2020
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 4/2020
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-020-01207-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria

CircMTO1 Attenuated Acute Kidney Injury Through Regulating miR-337

Titanium Ions Play a Synergistic Role in the Activation of NLRP3 Inflammasome in Jurkat T Cells

Downregulation of lncRNA NEAT1 Ameliorates LPS-Induced Inflammatory Responses by Promoting Macrophage M2 Polarization via miR-125a-5p/TRAF6/TAK1 Axis

Oat-Derived β-Glucans Induced Trained Immunity Through Metabolic Reprogramming

Patchouli Alcohol: a Natural Sesquiterpene Against Both Inflammation and Intestinal Barrier Damage of Ulcerative Colitis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin